Select Page

AI-Powered Target Discovery

Identify new drug targets and promising drug repurposing candidates quickly, easily and with high confidence

Graphwise’s Target Discovery helps pharma and biotech companies find the next therapeutic targets in a sea of disconnected data.

  • Accelerate clinical research at least 10x with AI-powered drug discovery. Easily and quickly mine relevant scientific information and explore new relationships across vast connected data sources;
  • Enrich your knowledge with an AI-powered therapeutic target database, automatically extracted from scientific publications, patents and study materials;
  • Utilize your scientific research advanced algorithms to analyze large and complex network relationships between biomedical entities effectively;
  • Embrace data-driven decision-making in target assessment and prioritization;
  • Promote innovation by using a digital pharma platform that adapts to your research and business needs in both new drug target discovery and repurposing of existing drugs;

Accelerate clinical research with AI-powered drug discovery tools.

Target-Disease Mapping

Discover previously unknown connections between targets and diseases, quickly generate and assess new ideas to guide drug research and development.

Multi-Source Data Integration

Leverage highly interlinked information across various data sources to boost drug development and drug repurposing

Complex Biomedical Data Analytics

Identify biomedical concepts and relationships in both unstructured and structured data to speed up novel therapies

About Graphwise Target Discovery

  • The challenge of drug discoveryDiscovering the next breakthrough drug candidate is a daunting task, involving sifting through vast amounts of biomedical information scattered across different databases and research publications. This process can be time-consuming and difficult to mine, gather and analyze.
  • Centralizing biomedical knowledgeGraphwise’s Target Discovery solves this by combining all the knowledge about biomedical entities, such as genes, proteins and compounds, into a centralized knowledge graph. The system democratizes data access to AI in biomedical engineering through powerful search tools, presents it in a user-friendly manner, and provides transparent analytics to aid data-driven decision-making.
  • AI-powered preclinical insightsUsing AI for preclinical research provides fast and easy access to facts generally hidden in millions of scientific publications and patents and predictions about novel relations between genes and diseases. The process of selecting the right candidate is further enhanced by comprehensive data provenance and confidence metrics for AI-driven drug discovery.

How it works

LinkedLifeData Inventory

Leverage pre-configured data sources from Graphwise LinkedLifeData inventory that covers concepts such as genes, proteins, drugs, pathways, clinical trials, scientific literature, patents, etc.

Who can benefit from Graphwise Target Discovery?

Scientists and Researchers

Typically, it’s challenging to find relevant information in the vast amount of scientific publications and make sense of both public and internally produced data. Target Discovery helps minimize difficulty in deciding what assays to prioritize based on all available information.

Pharma companies

Organize and semantically connect your disparate data to reveal hidden relationships and unlock deeper insights.

Research

Organize and semantically connect your disparate data to reveal hidden relationships and unlock deeper insights.

Case Study

Oxford Drug Discovery Institute Accelerated Alzheimer’s Breakthroughs by Harnessing Graphwise Target Discovery

Graphwise Target Discovery solution helped Oxford Drug Discovery Institute accelerate target analysis and decision-making

Read more

Customer Success Story

Accelerating Alzheimer’s Breakthroughs

Oxford Drug Discovery Institute leveraged Graphwise’s GraphDB and the Linked Life Data Inventory to support the team of scientists accelerating target analysis and decision-making by consolidating diverse data sources and enabling high-confidence target prioritization.

Read more

Blog

Accelerating End-to-end Knowledge Graph Solutions with Graphwsie LinkedLifeData Inventory: The Case of Target Discovery

LLD Inventory forms the semantic foundation for Graphwise Target Discovery solution.

Read more